H.R. 5969

119 HR 5969 IH: Linking Abortion-drug Batches for Enforcement and Liability Act
 U.S. House of Representatives
 2025-11-07
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I
 119th CONGRESS  1st Session
 H. R. 5969
 IN THE HOUSE OF REPRESENTATIVES
 November 7, 2025
  Mr. Moore of Alabama  (for himself,  Ms. Hageman ,  Mrs. Miller of Illinois ,  Mr. McGuire ,  Mr. Harris of Maryland ,  Mr. Palmer ,  Mr. Clyde , and  Mr. Pfluger ) introduced the following bill; which was referred to the  Committee on Energy and Commerce
 A BILL
To amend the Federal Food, Drug, and Cosmetic Act to ensure that abortion-inducing drugs bear a label identifying the name and address of the dispenser and the name of the prescriber, and for other purposes.
1.
Short title
This Act may be cited as the   Linking Abortion-drug Batches for Enforcement and Liability Act   or the   LABEL Act  .
2.
Labeling requirements for abortion-inducing drugs
(a)
In general
Section 503(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353(b) ) is amended by adding at the end the following:
(6)
(A)
Notwithstanding any other provision of this Act, in the case of an abortion-inducing drug, the drug shall be deemed to be misbranded unless the drug bears a label that identifies—
(i)
the name and address of the dispenser; and
(ii)
the name of the prescriber.
(B)
No State or political subdivision of a State may establish, continue in effect, or enforce a labeling requirement for an abortion-inducing drug that is not at least as stringent as the labeling requirement in subparagraph (A).
(C)
In this paragraph, the term  abortion-inducing drug —
(i)
means a drug that is intended, alone or in combination with 1 or more other drugs, for use or that is in fact used (irrespective of how the drug is labeled) to kill the unborn child of a woman known to be pregnant or to terminate the pregnancy of a woman known to be pregnant; but
(ii)
does not include a drug that is intended, alone or in combination with 1 or more other drugs, for use to remove a dead unborn child of a woman known to be pregnant or to treat an ectopic pregnancy.
 .
(b)
Severability
If any provision of this section, the amendment made by this section, or the application of such provision or amendment to any person or circumstance is held to be unconstitutional, the remainder of this section, the amendment made by this section, and the application of the provision to such person or circumstance shall not be affected thereby.